Carroll Financial Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Carroll Financial Associates’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$90K	Sell	143 -3	-2%	-$1.84K	﹤0.01%	554
2021 Q3	$88K	Buy	146 +7	+5%	+$4.35K	﹤0.01%	568
2021 Q2	$77K	Buy	139 +6	+5%	+$3.04K	﹤0.01%	663
2021 Q1	$62K	Sell	133 -2	-1%	-$974	﹤0.01%	712
2020 Q4	$65K	Buy	135 +83	+160%	+$44.8K	﹤0.01%	629
2020 Q3	$29K	Hold	52	–	–	﹤0.01%	778
2020 Q2	$32K	Sell	52 -723	-93%	-$410K	﹤0.01%	760
2020 Q1	$378K	Buy	775 +723	+1,390%	+$298K	0.04%	227
2019 Q4	$19K	Sell	52 -15	-22%	-$5.05K	﹤0.01%	894
2019 Q3	$18K	Hold	67	–	–	﹤0.01%	858
2019 Q2	$20K	Sell	67 -577	-90%	-$192K	﹤0.01%	831
2019 Q1	$264K	Buy	644 +577	+861%	+$238K	0.02%	282
2018 Q4	$26K	Hold	67	–	–	﹤0.01%	608
2018 Q3	$27K	Hold	67	–	–	﹤0.01%	634
2018 Q2	$23K	Hold	67	–	–	﹤0.01%	642
2018 Q1	$23K	Hold	67	–	–	﹤0.01%	634
2017 Q4	$25K	Hold	67	–	–	﹤0.01%	608
2017 Q3	$31K	Sell	67 -15	-18%	-$7.14K	﹤0.01%	572
2017 Q2	$40K	Hold	82	–	–	﹤0.01%	540
2017 Q1	$31K	Hold	82	–	–	﹤0.01%	571
2016 Q4	$30K	Sell	82 -20	-20%	-$7.61K	﹤0.01%	557
2016 Q3	$41K	Hold	102	–	–	0.01%	497
2016 Q2	$35K	Hold	102	–	–	0.01%	508
2016 Q1	$36K	Hold	102	–	–	0.01%	489
2015 Q4	$55K	Sell	102 -10	-9%	-$5.42K	0.01%	384
2015 Q3	$58K	Hold	112	–	–	0.01%	365
2015 Q2	$57K	Buy	112 +100	+833%	+$48.8K	0.01%	344
2015 Q1	$5K	Hold	12	–	–	﹤0.01%	639
2014 Q4	$5K	Sell	12 -100	-89%	-$39.3K	﹤0.01%	583
2014 Q3	$44K	Hold	112	–	–	0.01%	326
2014 Q2	$32K	Hold	112	–	–	0.01%	386
2014 Q1	$34K	Buy	112 +12	+12%	+$3.7K	0.01%	349
2013 Q4	$27K	Hold	100	–	–	0.01%	372
2013 Q3	$31K	Hold	100	–	–	0.01%	358
2013 Q2	$22K	Buy	+100	New	+$23.3K	0.01%	321

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Carroll Financial Associates's REGN Position: Q4 2021 in Review

Carroll Financial Associates reduced its Regeneron Pharmaceuticals (REGN) stake by 2.1% in Q4 2021, selling an estimated $1.84K and leaving 143 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Carroll Financial Associates first reported a position in REGN in Q2 2013 and has held it in 35 quarters since. The position peaked at $378K in Q1 2020. 1,079 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Carroll Financial Associates held 143 shares of Regeneron Pharmaceuticals worth $90K as of Q4 2021.
Carroll Financial Associates sold 3 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $1.84K.
Regeneron Pharmaceuticals made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #554 holding.
Carroll Financial Associates first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 35 quarters since.
Carroll Financial Associates's Regeneron Pharmaceuticals position peaked at $378K in Q1 2020.
1,079 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.